Disclosures

Nobody pays to read GLP Loss, so somebody else does. This page sets out how that works, what their money reaches, and what it does not reach. The standard it is written against is the FTC’s endorsement guides at 16 CFR Part 255, together with the agency’s guidance on making a disclosure clear and conspicuous rather than merely present.

1. How we are paid

Commission, on outbound clicks. Follow a link from here to a seller and sign up, and that seller may pay us. Your bill is unaffected: the figure you are quoted is the figure you would have been quoted arriving from a search result, an advert, or the address bar. The arrangement is a material connection in the FTC’s language, which is why it is stated here, on every page where it applies, and directly above the links rather than in a footer.

What appears on a given page is derived from that page’s own links at build time. Where none of them earn, the page says so plainly instead of reciting a precaution it does not need. A notice printed everywhere regardless is a notice nobody reads, and it tells you nothing about the page in front of you.

2. Who pays us

Commissions are recorded by a third-party affiliate network, the intermediary we work through. A fraction of the sellers covered here sit inside that arrangement. The large majority do not, and several are written up at length precisely because there is nothing in it for us.

A roster of those companies used to occupy this spot. It no longer does — not because the information is awkward, but because a policy page is the wrong surface to carry it. Commercial relationships open and close; a list read once and remembered is wrong later without anyone noticing. The disclosure worth having is the one attached to the link you are about to follow, and that one is derived at build time from the links sitting on the page in front of you.

Where one specific seller stands is a question we will answer directly. Write to corrections@glploss.com.

3. What the money buys, and what it does not

Position, and only position. A paying seller is grouped ahead of non-paying ones on a board and can appear in a promoted module. Wherever that happens the row carries a Partner label, so you can see the arrangement at the point it affects what you are looking at.

Not the assessment. A score, the reasoning behind a rank, a note about a seller’s own contradictions — none of it moves with payment, and refusing to work with us costs a company nothing in how it is written up. This is enforced rather than promised: the scoring function is never handed a seller’s commercial status, and a test fails the build if the same seller scores differently with it flipped. Nature of reviews sets out the mechanism.

4. Where the money stands today

Some of the sellers reviewed here are paying partners as of today, each carrying a Partner label wherever it appears and grouped ahead of the rest on its board. Everything else going out from this site stays editorial. Payment moves position and nothing further: the ordering of everyone below the partner block, and the score itself, come from the rubric, which is never shown who pays. Which companies those are is not withheld — it is only that the set turns over too often for any page to state it and stay true. Ask, and you will be told.

A recommendation we cannot be paid for is the strongest signal of independence we are able to give you, so we would rather point at it than ask you to take the firewall on trust.

5. Who we are, and what we do not cover

An independent publisher. Not a medical provider, not a pharmacy, not a telehealth company, and not affiliated with any manufacturer beyond ordinary affiliate agreements. We do not cover every GLP-1 seller in existence — coverage follows what readers are actually choosing between and where there is evidence to choose on.

6. Not medical advice

This is research and education, not medical advice, and it creates no doctor–patient relationship. GLP-1 is not right for everyone, and everything sold through telehealth today is compounded — not FDA-approved, and not reviewed by the FDA for safety, efficacy or quality before it reaches you. Talk to a licensed clinician before starting, stopping or changing anything. Prices and availability move constantly; check the provider’s own page before you act. Full terms are in our Terms of Use.

7. Trademarks

Provider and product names, logos and marks referenced here are the property of their respective owners and are used only to identify what is being discussed. Their use does not imply endorsement or affiliation.

8. Privacy

Following an affiliate link may pass a non-identifying referral code to the destination. It does not send them personal information about you from us, and our analytics do not load until you consent. See our Privacy Policy for how we handle data and your rights under GDPR and CCPA/CPRA.

9. Corrections and contact

Found an error, or think something here is out of date? Write to corrections@glploss.com. We fix things in public — see corrections.